Companies

Affimed NV

NASDAQ: AFMD

$0.18

▲ $0.00 (+0.00%) today

Markets closed · 7:40am ET

Today · % change

About AFMD

Affimed NV, a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. The company is headquartered in Heidelberg, Germany.

AFMD Coverage

11:40am ET

Investing

Great Employment Report, Bad Ramifications: Analysts Upgrade or Downgrade Ford, Kroger, Merck and More

Monday's additional top analyst upgrades and downgrades were on Bristol Myers Squibb, Ford, Fortinet, General Motors, Kraft Heinz, Kroger, Merck, Procter & Gamble, Toast and more.

AFMD BMY F

Chris Lange